Stocks STN Financial statements
Financial statementsSTANTEC INC financial statements
Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data STANTEC INC files with the SEC in its annual reports.
In CAD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2017 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4,300 | 4,029 | 4,284 | 4,827 | 4,730 | 4,577 | 5,677 | 6,480 | 7,500 | 8,144 |
| Cost of revenue | 1,422 | 1,412 | 1,540 | 1,703 | 1,754 | 1,673 | 2,040 | 2,322 | ||
| Gross profit | 1,676 | 1,762 | 1,815 | 2,008 | 1,931 | 1,963 | 2,417 | 2,745 | ||
| Selling, general and administrative | 1,335 | 1,408 | 1,438 | 1,434 | 1,353 | 1,424 | 1,743 | 1,965 | 2,286 | 2,458 |
| Pre-tax income | 181 | 264 | 226 | 266 | 217 | 263 | 325 | 408 | 465 | 630 |
| Income tax | 50.3 | 167 | 55 | 71.1 | 57.6 | 62.3 | 78.1 | 91.2 | 104 | 151 |
| Income from continuing operations | 97 | 171 | 194 | 159 | 201 | 247 | 317 | 362 | 479 | |
| Net income | 131 | 97 | 47.4 | 194 | 171 | 201 | 247 | 317 | 362 | 479 |
| EPS, basic | 1.17 | 0.81 | 0.40 | 1.66 | 1.46 | 1.72 | 2.13 | 2.85 | 3.17 | 4.20 |
| EPS, diluted | 1.17 | 0.81 | 0.40 | 1.66 | 1.46 | 1.72 | 2.12 | 2.85 | 3.17 | 4.20 |
Balance sheet
| FY2017 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 211 | 240 | 185 | 224 | 290 | 194 | 148 | 353 | 229 | 398 |
| Receivables | 806 | 816 | 878 | 818 | 738 | 824 | 1,028 | 1,064 | 1,324 | 1,307 |
| Total current assets | 1,583 | 1,608 | 1,636 | 1,580 | 1,565 | 1,664 | 1,938 | 2,273 | 2,549 | 2,791 |
| Property, plant and equipment | 214 | 213 | 289 | 287 | 240 | 234 | 251 | 268 | 299 | 308 |
| Lease right-of-use assets | 559 | 447 | 477 | 470 | 443 | 474 | 545 | |||
| Goodwill | 1,828 | 1,557 | 1,621 | 1,652 | 1,674 | 2,184 | 2,346 | 2,074 | 2,713 | 3,222 |
| Intangible assets | 450 | 262 | 248 | 220 | 182 | 373 | 320 | 266 | 427 | 595 |
| Total assets | 4,285 | 3,883 | 4,010 | 4,562 | 4,389 | 5,226 | 5,653 | 5,766 | 6,956 | 7,957 |
| Accounts payable | 718 | 705 | 567 | 576 | 576 | 635 | 756 | 842 | 1,019 | 1,125 |
| Total current liabilities | 1,073 | 1,156 | 894 | 1,006 | 987 | 1,179 | 1,410 | 1,617 | 1,979 | 2,266 |
| Lease liabilities | 589 | 526 | 545 | 522 | 478 | 529 | 585 | |||
| Total liabilities | 2,308 | 1,984 | 2,101 | 2,684 | 2,460 | 3,224 | 3,367 | 3,315 | 4,011 | 4,717 |
| Total debt | 1,021 | 740 | 934 | 861 | 681 | 1,245 | 1,236 | 1,098 | 1,384 | 1,818 |
| Retained earnings | 918 | 947 | 851 | 918 | 959 | 1,043 | 1,155 | |||
| Shareholders' equity | 1,976 | 1,896 | 1,876 | 1,876 | 1,929 | 2,002 | 1,992 | 2,451 | 2,945 | 3,240 |
| Minority interests | 0.8 | 3 | 1.8 | 1.6 | 0.8 | 0.5 | 0.4 | |||
| Total equity | 1,976 | 1,896 | 1,878 | 1,877 | 1,929 | 2,002 | 1,992 | 2,451 | 2,945 | 3,240 |
| Total liabilities and equity | 4,285 | 3,883 | 4,010 | 4,562 | 4,389 | 5,226 | 5,653 | 5,766 | 6,956 | 7,957 |
Cash flow statement
| FY2017 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income | 131 | 97 | 47.4 | 194 | 171 | 201 | 247 | 317 | 362 | 479 |
| Cash from operations | 286 | 264 | 173 | 453 | 604 | 397 | 304 | 520 | 603 | 863 |
| Capital expenditures | -58.3 | -58.9 | -125 | -56.7 | -31.2 | -45.8 | -68.5 | |||
| Cash from investing | -1,137 | 60.3 | -224 | -135 | -102 | -765 | -73.8 | -202 | -605 | -534 |
| Debt issued | 457 | 259 | ||||||||
| Debt repaid | -282 | -462 | -80.3 | -448 | ||||||
| Stock issued | 0 | 278 | 0 | |||||||
| Share buybacks | -18.2 | -14.4 | -74.7 | -41.2 | -80.3 | -50.7 | -65.3 | -10 | ||
| Dividends paid | -46.1 | -55.5 | -61.3 | -64 | -68 | -72.3 | -78.2 | -84.9 | -94 | -101 |
| Cash from financing | 995 | -281 | -24 | -286 | -413 | 277 | -297 | -109 | -152 | -140 |
| Exchange rate effect | -0.6 | -14.3 | 21.2 | -12.5 | -8.4 | -6.8 | 27.8 | -4.4 | 29.6 | -19.7 |
| Net change in cash | 144 | 28.6 | -54.3 | 18.8 | 80.8 | -98.1 | -38.4 | 205 | -124 | 170 |
| Free cash flow | 227 | 205 | 47.8 | 396 | 573 | 351 | 236 | |||
| Interest paid | 30.8 | 28.1 | 30.5 | 71.6 | 51.9 | 36.4 | 61.1 | 83.5 | 96.6 | 83.7 |
| Income taxes paid | 16.9 | 39.1 | -21.1 | 17.6 | -27.7 | 72.9 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Pre-tax margin | 7.7% | Pre-tax income / revenue. |
| Net margin | 5.9% | Net income / revenue. |
| Operating cash flow margin | 10.6% | Cash from operations / revenue. |
| Effective tax rate | 23.9% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 15.5% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 6.4% | Net income / average total assets. |
| SG&A / revenue | 30.2% | Selling, general and administrative expense / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 8.6% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 12.8% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 11.5% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | 32.6% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | 24.7% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | 22.9% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EPS growth, 1y | 32.5% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | 25.5% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS CAGR, 5y | 23.5% | Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 43.1% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 41.5% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 7.4% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 10.0% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 17.6% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 10.9% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 14.4% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 12.1% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 12.6% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.23x | Current assets / current liabilities. |
| Quick ratio | 0.75x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.18x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.56x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 22.9% | Total debt / total assets. |
| Liabilities / assets | 59.3% | Total liabilities / total assets. |
| Net debt | CA$1.42B | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Working capital | CA$524.8M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 48.0% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | -CA$575.9M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 1.09x | Revenue / average total assets. |
| Fixed asset turnover | 26.8x | Revenue / average property, plant and equipment. |
| Receivables turnover | 6.19x | Revenue / average receivables. |
| Days sales outstanding | 59 days | 365 x average receivables / revenue. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | CA$4.20 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | CA$4.20 | Net income per basic share, as reported (split-adjusted). |
| Payout ratio | 21.1% | Dividends paid / net income, when net income is positive. |
What was STANTEC INC's revenue in fiscal 2025?
STANTEC INC reported revenue of CA$8.14B for fiscal 2025, 8.6% higher than the year before.
Was STANTEC INC profitable in fiscal 2025?
Yes. Net income was CA$479.4M, a net margin of 5.9%.